Notizie/Reuters/EMA committee recommends approval for injectable version of Merck's KeytrudaEMA committee recommends approval for injectable version of Merck's KeytrudaRefinitivMeno di 1 minuto di letturaMRKMerck MRK said on Friday the European Medicines Agency's committee has recommended the approval for a new formulation of its MRK blockbuster cancer therapy Keytruda that can be administered under the skin.Azioni USAReuters© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlMostra di piùAccedi o crea un account gratuito per leggere queste notizieAndiamo
